Rich Horgan, the founder of the nonprofit Cure Rare Disease, is on a quest to develop a therapy for his brother Terry who was born with...
The burgeoning field of cell and gene therapies collectively referred to as Advanced Therapeutics (ADVTX), is at last beginning to...
Last week we introduced 5 key challenges that, based on interviews at various biotech congresses, appear to be at the forefront of...
Investment in gene therapy has continued to pay off as Sarepta Therapeutics recently announced positive results from phase 1/2a trial...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net
